Hostname: page-component-5c6d5d7d68-wp2c8 Total loading time: 0 Render date: 2024-08-15T22:10:46.789Z Has data issue: false hasContentIssue false

Stereotactic radiotherapy of orbital metastasis from malignant melanoma: a case study

Published online by Cambridge University Press:  21 November 2014

Wojciech Majewski*
Affiliation:
Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland
Jerzy Wydmanski
Affiliation:
Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland
Wojciech Rokicki
Affiliation:
Department and Clinic of Ophtalmology, Medical University of Silesia, Katowice, Poland
*
Correspondence to: Wojciech Majewski, Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-100 Gliwice, Poland. Tel: +48 2 2788001. E-mail: wmajewski1@poczta.onet.pl

Abstract

Objective:

Orbital metastases lead to many distressful symptoms.

Methods:

A case-report of a 44-year-old woman with a melanoma metastasis in the orbital cavity, is reported. A patient presented with headache, proptosis and diplopia. The stereotactic radiotherapy of 19.5 Gy in three fractions using CyberKnife was performed. Follow-up examination 7 months later revealed satisfactory local control of the tumour, alleviation of orbital symptoms with no negative impact on visual function.

Conclusion:

Stereotactic radiotherapy seems to be a safe and effective treatment of orbital metastases from melanoma.

Type
Case Study
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Tarhini, A A, Agarwala, S. Management of brain metastases in patients with melanoma. Curr Opin Oncol 2004; 16: 161166.Google Scholar
2.Char, D H, Miller, T, Kroll, S. Orbital metastases: diagnosis and course. Br J Ophthalmol 1997; 81: 386390.Google Scholar
3.Rosenberg, C, Finger, P T. Cutaneous malignant melanoma metastatic to the eye, lids and orbit. Surv Ophthalmol 2008; 53: 187202.CrossRefGoogle Scholar
4.Zografos, L, Ducrey, N, Beati, Det al. Metastatic melanoma in the eye and orbit. Ophthalmology 2003; 110: 22452256.Google Scholar
5.Calcerrada, D-S N, Blasco Amaro, J A, Cardiel, C A, Andradas Aragones, A. The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systemic review of the literature. Radiother Oncol 2008; 89: 245253.Google Scholar
6.Powell, J W, Chung, C T, Shah, H Ret al. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg 2008; 109: 122128.Google Scholar
7.Stinauer, M A, Kavanagh, B D, Schefter, T Eet al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol 2011; 6: 34.Google Scholar
8.Sambade, M J, Peters, E C, Thomas, N E, Kaufmann, W K, Kimple, R J, Shields, J M. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 2011; 98: 394399.Google Scholar
9.Klingenstein, A, Kufeld, M, Wowra, B, Muracevic, A, Furweger, C, Schaler, U C. CyberKnife radiosurgery for the treatment of orbital metastases. Technol Cancer Res Treat 2012; 11: 433439.Google Scholar
10.Adler, J R, Gibbs, I C, Putaweepong, P, Chang, S D. Visual field preservation after multisession CyberKnife radiosurgery for perioptic lesions. Neurosurgery 2006; 59: 244254.Google Scholar